These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16392218)

  • 1. Implantable defibrillators with and without resynchronization for patients with left ventricular dysfunction.
    Narayan SM
    Tex Heart Inst J; 2005; 32(3):358-61. PubMed ID: 16392218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation.
    Cantero-Pérez EM; Sobrino-Márquez JM; Grande-Trillo A; Lage-Gallé E; Rangel-Sousa D; Esteve-Ruiz IM; Martínez-Martínez A
    Transplant Proc; 2013; 45(10):3659-61. PubMed ID: 24314988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can cardiac resynchronization therapy be used as a tool to reduce sudden cardiac arrest risk?
    Galand V; Singh JP; Heist EK
    Prog Cardiovasc Dis; 2019; 62(3):242-248. PubMed ID: 31004607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Device therapies in the post-myocardial infarction patient with left ventricular dysfunction.
    Kadish AH; Reiffel JA; Naccarelli GV; DiMarco JP
    Am J Cardiol; 2008 Sep; 102(5A):29G-37G. PubMed ID: 18722189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.
    Gasparini M; Regoli F; Ceriotti C; Galimberti P; Bragato R; De Vita S; Pini D; Andreuzzi B; Mangiavacchi M; Klersy C
    Am Heart J; 2008 Mar; 155(3):507-14. PubMed ID: 18294488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do implantable cardioverter defibrillators improve survival in patients with severe left ventricular systolic dysfunction after coronary artery bypass graft surgery?
    Fazal IA; Bates MG; Matthews IG; Turley AJ
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1010-6. PubMed ID: 21398652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do implantable cardioverter defibrillators lower mortality risk in patients with cardiomyopathy?
    Gersh B
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):16-7. PubMed ID: 16265252
    [No Abstract]   [Full Text] [Related]  

  • 8. Noninvasive risk stratification for sudden death: signal-averaged electrocardiography, nonsustained ventricular tachycardia, heart rate variability, baroreflex sensitivity, and QRS duration.
    Stein KM
    Prog Cardiovasc Dis; 2008; 51(2):106-17. PubMed ID: 18774010
    [No Abstract]   [Full Text] [Related]  

  • 9. Implantable device therapy.
    Goldenberg I; Moss AJ
    Prog Cardiovasc Dis; 2008; 50(6):449-74. PubMed ID: 18474287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer Indications for ICD and CRT.
    Merriam JA; Rajendra AB; Gold MR
    Cardiol Clin; 2014 May; 32(2):181-90. PubMed ID: 24793795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention.
    Chan PS; Nallamothu BK; Spertus JA; Masoudi FA; Bartone C; Kereiakes DJ; Chow T
    Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):16-24. PubMed ID: 20031808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.
    Forleo GB; Della Rocca DG; Papavasileiou LP; Panattoni G; Sergi D; Duro L; Mahfouz K; Magliano G; Santini L; Romeo F
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):779-84. PubMed ID: 21941203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cardiac resynchronization therapy on subendo- and subepicardial left ventricular twist mechanics and relation to favorable outcome.
    Bertini M; Delgado V; Nucifora G; Marsan NA; Ng AC; Shanks M; Van Bommel RJ; Borleffs CJ; Ewe SH; Boriani G; Biffi M; Schalij MJ; Bax JJ
    Am J Cardiol; 2010 Sep; 106(5):682-7. PubMed ID: 20723646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revascularization versus implantable cardioverter-defibrillators to prevent sudden death in patients with severe left ventricular dysfunction.
    Weintraub WS
    Circulation; 2001 Sep; 104(13):1457-8. PubMed ID: 11571235
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of electrophysiology study in risk stratification of sudden cardiac death.
    Thomas KE; Josephson ME
    Prog Cardiovasc Dis; 2008; 51(2):97-105. PubMed ID: 18774009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
    Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shades of grey: the conundrum of implantable defibrillators in individuals with advanced CKD.
    Khattak A; Charytan DM
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1107-9. PubMed ID: 26111858
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.
    Pouleur AC; Knappe D; Shah AM; Uno H; Bourgoun M; Foster E; McNitt S; Hall WJ; Zareba W; Goldenberg I; Moss AJ; Pfeffer MA; Solomon SD;
    Eur Heart J; 2011 Jul; 32(14):1720-9. PubMed ID: 21609974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.